Northern Trust’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.21M | Buy |
575,383
+38,761
| +7% | +$620K | ﹤0.01% | 2123 |
|
|
2025
Q1 | $9.17M | Buy |
536,622
+9,255
| +2% | +$158K | ﹤0.01% | 2087 |
|
|
2024
Q4 | $13.1M | Buy |
527,367
+20,377
| +4% | +$505K | ﹤0.01% | 1967 |
|
|
2024
Q3 | $14.5M | Buy |
506,990
+43,269
| +9% | +$1.23M | ﹤0.01% | 1832 |
|
|
2024
Q2 | $12.2M | Sell |
463,721
-14,986
| -3% | -$396K | ﹤0.01% | 1878 |
|
|
2024
Q1 | $15.5M | Sell |
478,707
-15,987
| -3% | -$517K | ﹤0.01% | 1771 |
|
|
2023
Q4 | $20.8M | Buy |
494,694
+15,326
| +3% | +$646K | ﹤0.01% | 1590 |
|
|
2023
Q3 | $18.4M | Sell |
479,368
-13,492
| -3% | -$518K | ﹤0.01% | 1602 |
|
|
2023
Q2 | $9.35M | Buy |
492,860
+81,813
| +20% | +$1.55M | ﹤0.01% | 2113 |
|
|
2023
Q1 | $6.38M | Sell |
411,047
-6,896
| -2% | -$107K | ﹤0.01% | 2308 |
|
|
2022
Q4 | $7.42M | Buy |
417,943
+68,068
| +19% | +$1.21M | ﹤0.01% | 2215 |
|
|
2022
Q3 | $1.95M | Sell |
349,875
-7,366
| -2% | -$41.1K | ﹤0.01% | 3024 |
|
|
2022
Q2 | $1.39M | Sell |
357,241
-11,245
| -3% | -$43.9K | ﹤0.01% | 3235 |
|
|
2022
Q1 | $2.03M | Sell |
368,486
-20,910
| -5% | -$115K | ﹤0.01% | 3094 |
|
|
2021
Q4 | $3.32M | Sell |
389,396
-1,649
| -0.4% | -$14.1K | ﹤0.01% | 2953 |
|
|
2021
Q3 | $3.4M | Sell |
391,045
-26,265
| -6% | -$228K | ﹤0.01% | 2985 |
|
|
2021
Q2 | $4.41M | Sell |
417,310
-32,341
| -7% | -$342K | ﹤0.01% | 2917 |
|
|
2021
Q1 | $7.21M | Sell |
449,651
-17,187
| -4% | -$276K | ﹤0.01% | 2513 |
|
|
2020
Q4 | $21.6M | Buy |
466,838
+37,807
| +9% | +$1.75M | ﹤0.01% | 1736 |
|
|
2020
Q3 | $15.1M | Buy |
429,031
+155,699
| +57% | +$5.48M | ﹤0.01% | 1835 |
|
|
2020
Q2 | $6.66M | Buy |
273,332
+251,701
| +1,164% | +$6.13M | ﹤0.01% | 2350 |
|
|
2020
Q1 | $337K | Sell |
21,631
-1,943
| -8% | -$30.3K | ﹤0.01% | 3547 |
|
|
2019
Q4 | $374K | Buy |
+23,574
| New | +$374K | ﹤0.01% | 3628 |
|